Provenienza dei contatti di primo grado di Temre Johnson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 26 | |
| Public Company | Biotechnology | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Temre Johnson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Director of Finance/CFO Corporate Officer/Principal | |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Chairman Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| Indiana University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cincinnati (Ohio) | College/University | Masters Business Admin Undergraduate Degree | |
| Technische Universität München | College/University | Doctorate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Tavistock Life Sciences Co.
 Tavistock Life Sciences Co. Investment ManagersFinance Tavistock Life Sciences Co (Tavistock Life Sciences Co.) is a venture capital firm founded in 2002. The firm is headquartered in San Diego, California. | Investment Managers | Corporate Officer/Principal Sales & Marketing | |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a private company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin | |
| Washington University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Founder Private Equity Investor | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member Chairman | |
Nucleus Biologics LLC
 Nucleus Biologics LLC BiotechnologyHealth Technology Nucleus Biologics LLC develops cellular immunotherapies. Its products include PhysiologixTM XF SR, Vitronectin XF, Australia and New Zealand Origin FBS and zIsletTM media. The firm offers complete media manufacturing services. The company was founded in 2016 and is headquartered in San Diego, CA. | Biotechnology | Chairman Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Irlanda | 2 |
| Regno Unito | 2 |
| Germania | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 218 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 77 |
| Chairman | 51 |
| Chief Executive Officer | 44 |
Contatti più connessi
| Insiders | |
|---|---|
| James Topper | 49 |
| Peter Thompson | 39 |
| Michael Grey | 32 |
| Julie Cherrington | 32 |
| Xiang Ming Cui | 31 |
| Faheem Hasnain | 27 |
| Neil Reisman | 23 |
| Robert Conway | 21 |
| Aaron Davis | 19 |
| David Meek | 18 |
| Shalini Sharp | 17 |
| Mitchell Gold | 15 |
| Chris LeMasters | 15 |
| Laurie Stelzer | 13 |
| Joseph Leveque | 12 |
- Borsa valori
- Insiders
- Temre Johnson
- Connessioni Società
